Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 DiabetesDeborah J. Wexler, Gabriela Montes, Ian H. de Boer et al.|JAMA Internal Medicine|2023Cited by 38
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body WeightWilliam I. Sivitz, Analyn Uy, Neda Rasouli et al.|Diabetes Care|2020Cited by 27
Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study CohortNeda Rasouli, Kris Chionh, Naji Younes et al.|Diabetes Care|2020Cited by 20
Rationale and Design for a GRADE Substudy of Continuous Glucose MonitoringMary Larkin, Faramarz Ismail‐Beigi, David M. Nathan et al.|Diabetes Technology & Therapeutics|2019Cited by 11
Glucose-Lowering Medications, Glycemia, and Cognitive OutcomesJosé A. Luchsinger, Erica Gonzalez, Samuel P. Rosin et al.|JAMA Internal Medicine|2025Cited by 10